Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
Clinical trial NCT00439959 · TERMINATED
Trial details
- NCT number
- NCT00439959
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.